CIK 0001860871
- Emerging growth company
Tevogen Inc.
Sign in to watch- Ticker
- TVGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 981597194
- Phone
- +1 646-807-8832
- Business address
- 15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN, NJ, 07059
- Former names
- Tevogen Bio Holdings Inc., Semper Paratus Acquisition Corp
Securities
- TVGN Common Stock Nasdaq
- TVGNW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-11 | Saadi Ryan H. Chief Executive Officer | Gift | −460,000 | 124,334,453.32 | ||
| 2025-08-15 | Saadi Ryan H. Chief Executive Officer | Gift | −20,000 | 124,794,453.32 | ||
| 2025-06-27 | Saadi Ryan H. Chief Executive Officer | Grant or award | +8,000,000 | 124,814,453.32 | ||
| 2025-06-27 | Khan Sadiq Chief Commercial Officer | Grant or award | +200,000 | 1,169,618 | ||
| 2025-06-27 | Flomenberg Neal See Remarks | Grant or award | +300,000 | 3,895,608 | ||
| 2025-06-27 | Desai Kirti Chief Financial Officer | Grant or award | +750,000 | 10,449,186 | ||
| 2025-06-09 | Saadi Ryan H. Chief Executive Officer | Sale | −1,438,206 | $1.23 | $1.8M | 116,814,453.32 |
| 2025-03-12 | Flomenberg Neal See Remarks | Sale | −232,968 | $1.09 | $254K | 3,595,608 |
| 2025-03-11 | Flomenberg Neal See Remarks | Sale | −70,252 | $1.05 | $74K | 3,828,576 |
| 2025-03-10 | Flomenberg Neal See Remarks | Sale | −70,384 | $1.09 | $77K | 3,898,828 |
| 2025-03-07 | Flomenberg Neal See Remarks | Sale | −71,273 | $1.14 | $81K | 3,969,212 |
| 2025-03-06 | Flomenberg Neal See Remarks | Sale | −88,519 | $1.10 | $97K | 4,040,485 |
| 2025-03-05 | Flomenberg Neal See Remarks | Sale | −110,659 | $1.21 | $134K | 4,129,004 |
| 2025-03-04 | Flomenberg Neal See Remarks | Sale | −14,639 | $1.28 | $19K | 4,239,663 |
| 2024-12-23 | Feike Jeffrey L. Director | Grant or award | +240,000 | 821,771 | ||
| 2024-12-23 | Patton Curtis L. Director | Grant or award | +240,000 | 1,209,618 | ||
| 2024-12-23 | PODLOGAR SUSAN M Director | Grant or award | +240,000 | 433,923 | ||
| 2024-12-23 | Sordillo Victor J. Director | Grant or award | +240,000 | 336,962 | ||
| 2024-12-23 | Sordillo Victor J. Director | Grant or award | +240,000 | 576,962 | ||
| 2024-12-23 | Goh Keow Lin Director | Grant or award | +240,000 | 433,923 |
Page 2 of 4 · 64 trades